remifentanil has been researched along with Cerebrovascular Moyamoya Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, Y; Nakatani, K; Yagi, M; Yamama, Y | 1 |
| Fujino, Y; Hayashi, Y; Imada, T; Ota, C; Shiono, S | 1 |
2 other study(ies) available for remifentanil and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
[General Anesthesia with Remifentanil for Cesarean Section in a Patient with Moyamoya Disease].
Topics: Adult; Anesthesia, General; Anesthesia, Obstetrical; Apgar Score; Cesarean Section; Female; Hemodynamics; Humans; Hypertension; Infant, Newborn; Intubation, Intratracheal; Moyamoya Disease; Pregnancy; Pregnancy Complications; Remifentanil | 2016 |
[Anesthetic Management of a Patient with Quasi-moyamoya Disease Undergoing Total Thyroidectomy for Graves' Disease].
Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Dexamethasone; Drug Combinations; Female; Graves Disease; Humans; Methyl Ethers; Moyamoya Disease; Perioperative Care; Piperidines; Remifentanil; Sevoflurane; Thyroidectomy | 2015 |